Annual FCF
-$79.63 M
-$11.46 M-16.81%
December 31, 2023
Summary
- As of February 24, 2025, ACRS annual free cash flow is -$79.63 million, with the most recent change of -$11.46 million (-16.81%) on December 31, 2023.
- During the last 3 years, ACRS annual FCF has fallen by -$40.55 million (-103.74%).
- ACRS annual FCF is now -1518.58% below its all-time high of -$4.92 million, reached on December 31, 2013.
Performance
ACRS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$22.00 M
+$34.31 M+278.75%
September 30, 2024
Summary
- As of February 24, 2025, ACRS quarterly free cash flow is $22.00 million, with the most recent change of +$34.31 million (+278.75%) on September 30, 2024.
- Over the past year, ACRS quarterly FCF has increased by +$46.64 million (+189.28%).
- ACRS quarterly FCF is now at all-time high.
Performance
ACRS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$18.46 M
+$46.64 M+71.64%
September 30, 2024
Summary
- As of February 24, 2025, ACRS TTM free cash flow is -$18.46 million, with the most recent change of +$46.64 million (+71.64%) on September 30, 2024.
- Over the past year, ACRS TTM FCF has increased by +$73.19 million (+79.86%).
- ACRS TTM FCF is now -541.19% below its all-time high of -$2.88 million, reached on March 31, 2015.
Performance
ACRS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ACRS Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -16.8% | +189.3% | +79.9% |
3 y3 years | -103.7% | +306.3% | +58.1% |
5 y5 years | +22.1% | +191.0% | +74.8% |
ACRS Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -51.9% | at low | at high | +181.8% | at high | +79.9% |
5 y | 5-year | -103.7% | +18.8% | at high | +181.8% | at high | +81.2% |
alltime | all time | -1518.6% | +22.1% | at high | +169.6% | -541.2% | +83.5% |
Aclaris Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $22.00 M(-278.7%) | -$18.46 M(-71.6%) |
Jun 2024 | - | -$12.31 M(-41.3%) | -$65.10 M(-11.6%) |
Mar 2024 | - | -$20.95 M(+190.9%) | -$73.68 M(-7.5%) |
Dec 2023 | -$79.63 M(+16.8%) | -$7.20 M(-70.8%) | -$79.63 M(-13.1%) |
Sep 2023 | - | -$24.64 M(+18.0%) | -$91.65 M(+22.2%) |
Jun 2023 | - | -$20.89 M(-22.4%) | -$74.98 M(+1.4%) |
Mar 2023 | - | -$26.91 M(+40.0%) | -$73.94 M(+8.5%) |
Dec 2022 | -$68.17 M(+30.0%) | -$19.22 M(+141.2%) | -$68.17 M(+2.9%) |
Sep 2022 | - | -$7.97 M(-59.9%) | -$66.23 M(-3.9%) |
Jun 2022 | - | -$19.85 M(-6.1%) | -$68.92 M(+12.4%) |
Mar 2022 | - | -$21.13 M(+22.3%) | -$61.34 M(+17.0%) |
Dec 2021 | -$52.44 M(+34.2%) | -$17.27 M(+62.0%) | -$52.44 M(+19.1%) |
Sep 2021 | - | -$10.66 M(-13.1%) | -$44.03 M(-3.9%) |
Jun 2021 | - | -$12.27 M(+0.3%) | -$45.82 M(+3.2%) |
Mar 2021 | - | -$12.23 M(+38.0%) | -$44.39 M(+13.6%) |
Dec 2020 | -$39.09 M(-60.1%) | -$8.87 M(-28.8%) | -$39.09 M(-23.2%) |
Sep 2020 | - | -$12.45 M(+14.9%) | -$50.88 M(-18.7%) |
Jun 2020 | - | -$10.84 M(+56.4%) | -$62.60 M(-14.7%) |
Mar 2020 | - | -$6.93 M(-66.5%) | -$73.39 M(-25.2%) |
Dec 2019 | -$98.06 M | -$20.66 M(-14.6%) | -$98.06 M(-6.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2019 | - | -$24.18 M(+11.9%) | -$104.80 M(-5.6%) |
Jun 2019 | - | -$21.62 M(-31.6%) | -$111.03 M(-0.5%) |
Mar 2019 | - | -$31.60 M(+15.4%) | -$111.60 M(+9.2%) |
Dec 2018 | -$102.17 M(+82.8%) | -$27.39 M(-9.9%) | -$102.17 M(+9.2%) |
Sep 2018 | - | -$30.42 M(+37.1%) | -$93.56 M(+21.3%) |
Jun 2018 | - | -$22.18 M(+0.1%) | -$77.13 M(+18.3%) |
Mar 2018 | - | -$22.17 M(+18.0%) | -$65.21 M(+16.7%) |
Dec 2017 | -$55.90 M(+60.5%) | -$18.79 M(+34.3%) | -$55.90 M(+23.5%) |
Sep 2017 | - | -$13.98 M(+36.1%) | -$45.24 M(+9.7%) |
Jun 2017 | - | -$10.27 M(-20.1%) | -$41.23 M(+1.2%) |
Mar 2017 | - | -$12.85 M(+58.0%) | -$40.76 M(+17.0%) |
Dec 2016 | -$34.84 M(+66.9%) | -$8.13 M(-18.4%) | -$34.84 M(+12.5%) |
Sep 2016 | - | -$9.97 M(+1.7%) | -$30.97 M(-2.3%) |
Jun 2016 | - | -$9.80 M(+41.3%) | -$31.70 M(+27.2%) |
Mar 2016 | - | -$6.93 M(+62.4%) | -$24.93 M(+19.4%) |
Dec 2015 | -$20.88 M(+159.2%) | -$4.27 M(-60.1%) | -$20.88 M(+25.7%) |
Sep 2015 | - | -$10.70 M(+253.5%) | -$16.61 M(+181.2%) |
Jun 2015 | - | -$3.03 M(+5.1%) | -$5.91 M(+105.1%) |
Mar 2015 | - | -$2.88 M | -$2.88 M |
Dec 2014 | -$8.05 M(+63.7%) | - | - |
Dec 2013 | -$4.92 M | - | - |
FAQ
- What is Aclaris Therapeutics annual free cash flow?
- What is the all time high annual FCF for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual FCF year-on-year change?
- What is Aclaris Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly FCF year-on-year change?
- What is Aclaris Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM FCF year-on-year change?
What is Aclaris Therapeutics annual free cash flow?
The current annual FCF of ACRS is -$79.63 M
What is the all time high annual FCF for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual free cash flow is -$4.92 M
What is Aclaris Therapeutics annual FCF year-on-year change?
Over the past year, ACRS annual free cash flow has changed by -$11.46 M (-16.81%)
What is Aclaris Therapeutics quarterly free cash flow?
The current quarterly FCF of ACRS is $22.00 M
What is the all time high quarterly FCF for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly free cash flow is $22.00 M
What is Aclaris Therapeutics quarterly FCF year-on-year change?
Over the past year, ACRS quarterly free cash flow has changed by +$46.64 M (+189.28%)
What is Aclaris Therapeutics TTM free cash flow?
The current TTM FCF of ACRS is -$18.46 M
What is the all time high TTM FCF for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM free cash flow is -$2.88 M
What is Aclaris Therapeutics TTM FCF year-on-year change?
Over the past year, ACRS TTM free cash flow has changed by +$73.19 M (+79.86%)